RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Total non-current liabilities

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.6B
P/E ratio
12.3x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Sep 30, 202514,912+72.61%
Sep 30, 20248,639-39.94%
Sep 30, 202314,383-8.71%
Sep 30, 202215,756+38.64%
Sep 30, 202111,365+3.36%
Sep 30, 202010,996+17.48%
Sep 30, 20199,360+50.48%
Sep 30, 20186,220+14.42%
Sep 30, 20175,436-12.05%
Sep 30, 20166,181-0.15%
Sep 30, 20156,190-20.27%
Sep 30, 20147,764

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)